These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 3875804

  • 1. Similar distribution of monoamine oxidase (MAO) and parkinsonian toxin (MPTP) binding sites in human brain.
    Reznikoff G, Manaker S, Parsons B, Rhodes CH, Rainbow TC.
    Neurology; 1985 Oct; 35(10):1415-9. PubMed ID: 3875804
    [Abstract] [Full Text] [Related]

  • 2. Localization in rat brain of binding sites for parkinsonian toxin MPTP: similarities with [3H]pargyline binding to monoamine oxidase.
    Rainbow TC, Parsons B, Wieczorek CM, Manaker S.
    Brain Res; 1985 Mar 25; 330(2):337-42. PubMed ID: 3872699
    [Abstract] [Full Text] [Related]

  • 3. [3H]tryptamine binding sites are not identical to monoamine oxidase in rat brain.
    Perry DC, Grimm LJ, Kettler KG, Kellar KJ.
    J Neurochem; 1988 Nov 25; 51(5):1535-40. PubMed ID: 3139835
    [Abstract] [Full Text] [Related]

  • 4. Involvement of monoamine oxidase enzymes in the action of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, a selective neurotoxin, in the squirrel monkey: binding and biochemical studies.
    Del Zompo M, Piccardi MP, Bernardi F, Bonuccelli U, Corsini GU.
    Brain Res; 1986 Jul 23; 378(2):320-4. PubMed ID: 3089539
    [Abstract] [Full Text] [Related]

  • 5. High-affinity binding sites for [3H]MPTP may correspond to monamine oxidase.
    Parsons B, Rainbow TC.
    Eur J Pharmacol; 1984 Jul 13; 102(2):375-7. PubMed ID: 6332739
    [No Abstract] [Full Text] [Related]

  • 6. Correlation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity with blood-brain barrier monoamine oxidase activity.
    Kalaria RN, Mitchell MJ, Harik SI.
    Proc Natl Acad Sci U S A; 1987 May 13; 84(10):3521-5. PubMed ID: 3495000
    [Abstract] [Full Text] [Related]

  • 7. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites.
    Itzhak Y, Mash D, Zhang SH, Stein I.
    Mol Pharmacol; 1991 Mar 13; 39(3):385-93. PubMed ID: 1848660
    [Abstract] [Full Text] [Related]

  • 8. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: characterization and localization of receptor binding sites in rat and human brain.
    Javitch JA, Uhl GR, Snyder SH.
    Proc Natl Acad Sci U S A; 1984 Jul 13; 81(14):4591-5. PubMed ID: 6611553
    [Abstract] [Full Text] [Related]

  • 9. Normal MPTP binding in parkinsonian substantial nigra: evidence for extraneuronal toxin conversion in human brain.
    Uhl GR, Javitch JA, Snyder SH.
    Lancet; 1985 Apr 27; 1(8435):956-7. PubMed ID: 2859415
    [Abstract] [Full Text] [Related]

  • 10. Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP.
    Salach JI, Singer TP, Castagnoli N, Trevor A.
    Biochem Biophys Res Commun; 1984 Dec 14; 125(2):831-5. PubMed ID: 6335034
    [Abstract] [Full Text] [Related]

  • 11. Pargyline prevents MPTP-induced parkinsonism in primates.
    Langston JW, Irwin I, Langston EB, Forno LS.
    Science; 1984 Sep 28; 225(4669):1480-2. PubMed ID: 6332378
    [Abstract] [Full Text] [Related]

  • 12. Histochemistry of MPTP oxidation in the rat brain: sites of synthesis of the parkinsonism-inducing toxin MPP+.
    Nakamura S, Vincent SR.
    Neurosci Lett; 1986 Apr 24; 65(3):321-5. PubMed ID: 3487052
    [Abstract] [Full Text] [Related]

  • 13. Properties of 3H-MPTP binding sites in human blood platelets.
    Del Zompo M, Bernardi F, Bonuccelli U, Maggio R, Bajorek M, Arnone M, Corsini GU.
    Life Sci; 1986 Nov 17; 39(20):1885-91. PubMed ID: 3490614
    [Abstract] [Full Text] [Related]

  • 14. Studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Cohen G, Mytilineou C.
    Life Sci; 1985 Jan 21; 36(3):237-42. PubMed ID: 3917526
    [Abstract] [Full Text] [Related]

  • 15. Metabolism of the neurotoxin in MPTP by human liver monoamine oxidase B.
    Fritz RR, Abell CW, Patel NT, Gessner W, Brossi A.
    FEBS Lett; 1985 Jul 08; 186(2):224-8. PubMed ID: 3874094
    [Abstract] [Full Text] [Related]

  • 16. Primate-rodent 3H-MPTP binding differences, and biotransformation of MPTP to a reactive intermediate in vitro.
    Corsini GU, Pintus S, Bocchetta A, Piccardi MP, Del Zompo M.
    J Neural Transm Suppl; 1986 Jul 08; 22():55-60. PubMed ID: 3097260
    [Abstract] [Full Text] [Related]

  • 17. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.
    Javitch JA, D'Amato RJ, Strittmatter SM, Snyder SH.
    Proc Natl Acad Sci U S A; 1985 Apr 08; 82(7):2173-7. PubMed ID: 3872460
    [Abstract] [Full Text] [Related]

  • 18. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. I. Evaluation of the biological activity of MPTP analogs.
    Youngster SK, Sonsalla PK, Sieber BA, Heikkila RE.
    J Pharmacol Exp Ther; 1989 Jun 08; 249(3):820-8. PubMed ID: 2786564
    [Abstract] [Full Text] [Related]

  • 19. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
    Gnanalingham KK, Smith LA, Hunter AJ, Jenner P, Marsden CD.
    Synapse; 1993 Jun 08; 14(2):184-94. PubMed ID: 8332947
    [Abstract] [Full Text] [Related]

  • 20. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the dog: effect of pargyline pretreatment.
    Johannessen JN, Chiueh CC, Bacon JP, Garrick NA, Burns RS, Weise VK, Kopin IJ, Parisi JE, Markey SP.
    J Neurochem; 1989 Aug 08; 53(2):582-9. PubMed ID: 2568405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.